PSUSA/00002156/202508
PSUSA/00002156/202508
PSUSA/00002156/202508
PSUSA/00001945/202508
PSUSA/00010224/202508
PSUSA/00002605/202509
Orphan designation: povetacicept Treatment of primary membranous nephropathy, 23/02/2026 Positive
Records of data processing activity for the EudraVigilance Signal and Safety Analytics (EV SSA) platform
PDCO minutes of the 24-27 February 2026 meeting
Orphan designation: 2-[[(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazol-5-ol Treatment of multiple system atrophy, 09/01/2026 Positive
Orphan designation: N-[5-(2H-1,3-Benzodioxol-5-yl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]-N'-(2-methoxyethyl)sulfuric diamide Treatment of primary IgA nephropathy, 09/01/2026 Positive
Orphan designation: aminolevulinic acid hydrochloride Diagnosis of ovarian cancer, 09/01/2026 Positive